Pricefx Reimagines Pricing Software with Groundbreaking Product Enhancements
2.12.2020 17:30:00 EET | Business Wire | Press release
Pricefx, the global leader in cloud-native pricing software, today announced the new face of its pricing platform. Unity UI is a sleek, dynamic new look for all of Pricefx’s industry-leading pricing modules. The company has also launched PriceOptimizer AI, a next-generation price optimization solution powered by transparent and predictive machine learning and multi-agent AI. Finally, Pricefx introduced new Accelerators, pre-defined solution building blocks that quickly and easily incorporate best practice functionality. With these new enhancements, Pricefx is now more streamlined, powerful and agile than ever before. Now, businesses using Pricefx can get more done and price more effectively with fewer clicks.
“2020 revealed the critical importance of pricing in a digital-first world and Pricefx invested heavily in developing and refining our pricing platform to ensure that businesses around the world can successfully use our software to build a path to growth,” said Marcin Cichon, CEO and co-founder at Pricefx. “From the new, modern user interface to the groundbreaking AI-powered price optimizer and the pre-built Accelerators, Pricefx is delivering impressive product functionality to the market. We continue to live our commitment to providing customers fast, flexible and friendly solutions that help them achieve revenue and profit goals faster than ever.”
Unity UI
Pricefx platform modules are now unified in a modern, sleek UI that streamlines the user experience by ensuring that everything is at the user’s fingertips. Pricing workflows are simplified with a single application that works across multiple platforms and devices. To reduce management overhead, Pricefx can be customized for different users and easily incorporated into third-party CRM or ERP applications.
PriceOptimizer AI
With PriceOptimizer AI, Pricefx is introducing the industry’s first price optimization engine powered by multi-agent AI, a powerful approach that uses multiple interacting intelligent agents to arrive at the best outcome. With this breakthrough, PriceOptimizer AI can simulate multiple business objectives at once and simultaneously optimize the entire price waterfall at every level of granularity, from list prices to rebates. This means Pricefx customers can align competing business rules, priorities and constraints, such as price increases, competition or margin targets, resulting in far more realistic pricing strategy.
Additionally, users can evaluate multiple best outcomes even when the model is over constrained. They can model price elasticity to see precisely which constraints are impacting the optimized list price, discount or rebate. Then, users can easily change models, simulate the impact of changes and adjust constraints during run-time. This faster, more flexible approach to price optimization achieves massive time savings, with updates to thousands of prices and sales conditions in just minutes.
In combination with “clear box” segmentation and predictive ML algorithms, PriceOptimizer AI delivers transparent and intuitive price optimization, enabling pricing leaders to confidentially arm sales with deal guidance they can stand behind.
“Although the term ‘artificial intelligence’ can conjure up an image of robots taking over the world, the best use of AI is eliminating robotic work from a process so that people are free to use their experience and judgment to make better decisions more consistently,” observed Robert Kugel, Senior Vice President and Research Director at Ventana Research. “Making decisions about optimal pricing within a set of prioritized objectives, business rules and constraints is an ideal use case for AI provided that the system is fully transparent so individuals can trust the outcome. Increasingly, companies are finding that intelligent pricing enables them to improve both revenues and margins with a sustainable competitive advantage.”
Accelerators
With Pricefx Accelerators, customers can use pre-defined solution building blocks to deploy new modules and functionality even faster, while reducing overall effort and cost. By adding industry best practice functionality, Pricefx customers and partners can quickly and easily configure solutions out of the box, while still retaining customization capabilities. Not only do Accelerators reduce implementation effort and time to value, they also lower the total cost of ownership for the Pricefx platform by making it easier to support and enhance functionality.
Specifically, the new Sales Insights Accelerator delivers rapid insights into profitability, margin leakage and profit outliers. Customers can see how margin and revenue change over time based on factors like customer acquisition and variances in price, as well as quickly find and address outliers by analyzing your best and worst performing customers and products.
Availability
Unity UI, PriceOptimizer AI and Accelerators are generally available now as part of the Vesper release.
About Pricefx
Established in 2011 in Germany, Pricefx is the global leader in SaaS pricing software, offering a comprehensive suite of solutions that are fast to implement, flexible to configure and customize, and friendly to learn and use. Pricefx delivers a complete price optimization and management platform based on native cloud architecture, providing industry leading time to value and total cost of ownership advantages to customers. Their innovative solution works for both B2B and B2C enterprises of any size, in any industry, in any part of the world. Pricefx’s business model is entirely based on the satisfaction and loyalty of its customers. Today, Pricefx delivers Passion for Pricing to more than 100 customers in more than 37 countries worldwide. For more information, please visit www.pricefx.com .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201202005174/en/
Contact information
Media Contact:
Cathy Summers
Summers PR
cathy@summers-pr.com
+1 (415) 483-0480
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
